Chattem, Inc.???s Xyzal Allergy 24HR Launches To OTC Market Post author:Sam Post published:March 29, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Xenex Locks in $38 Million in Funding February 23, 2017 Incyte Release: Combination Of Epacadostat Plus Keytruda (Pembrolizumab) Demonstrates Activity In Clinical Trial Of Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) June 4, 2017 Juno Appoints To Board Of Directors May 22, 2017
Incyte Release: Combination Of Epacadostat Plus Keytruda (Pembrolizumab) Demonstrates Activity In Clinical Trial Of Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) June 4, 2017